Plain-English translation of NCT06738758 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether starting a newer cholesterol-lowering medication called a early during your hospital stay after a heart attack helps get your cholesterol to safer levels faster than traditional treatments. Researchers want to see if this medication, used alone or combined with other cholesterol drugs, can reduce future heart problems in people recovering from a heart attack.
After a heart attack, lowering cholesterol quickly is important to prevent another one, but standard treatments don't always work fast enough. This study wants to find out if the newer medication can reach cholesterol goals more quickly and help keep patients healthier long-term.
You likely qualify if…
You likely don't qualify if…
You would be assigned to receive one of three cholesterol treatment plans: the newer medication (with or without other cholesterol drugs), a combination of standard cholesterol drugs, or standard medication alone. You'll have blood tests and checkups at the hospital, at discharge, and then at 1, 3, 6, and 12 months after leaving the hospital to see how well the treatment works and to watch for any heart problems.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
China